DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV)

被引：6
|
作者：
Cannon, Christopher P.
McGuire, Darren
Pratley, Richard
Dagogo-Jack, Samuel
Mancuso, James
Huyck, Susan
Charbonnel, Bernard
Shih, Weichung
Gallo, Silvina
Masiukiewicz, Urszula
Golm, Gregory
Francesco, Cosentino
Lauring, Brett
Terra, Steven
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32366-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1825
引用
收藏
页码：1825 / 1825
页数：1
相关论文
共 50 条
  • [1] Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
    Cannon, Christopher P.
    Mcguire, Darren K.
    Pratley, Richard
    Dagogo-Jack, Sam
    Mancuso, James
    Huyck, Susan
    Charbonnel, Bernard
    Shih, Weichung J.
    Gallo, Silvina
    Masiukiewicz, Urszula
    Golm, Gregory
    Cosentino, Francesco
    Lauring, Brett
    Terra, Steven G.
    [J]. AMERICAN HEART JOURNAL, 2018, 206 : 11 - 23
  • [2] Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
    McGuire, D. K.
    Cannon, C. P.
    Pratley, R.
    Dagogo-Jack, S.
    Mancuso, J.
    Huyck, S.
    Charbonnel, B.
    Shih, W. J.
    Gallo, S.
    Masiukiewicz, U.
    Golm, G.
    Cosentino, F.
    Lauring, B.
    Terra, S. G.
    [J]. DIABETOLOGIA, 2018, 61 : S305 - S306
  • [3] Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial?
    Cowart, Kevin
    Carris, Nicholas W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (02) : 163 - 165
  • [4] Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial
    Cherney, David Z. I.
    Cosentino, Francesco
    McGuire, Darren K.
    Kolkailah, Ahmed A.
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Frederich, Robert
    Maldonado, Mario
    Liu, Chih-Chin
    Cannon, Christopher P.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 746 - 753
  • [5] Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
    Cosentino, Francesco
    Cannon, Christopher P.
    Frederich, Robert
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Mancuso, James P.
    Maldonado, Mario
    Cater, Nilo B.
    Wang, Shuai
    McGuire, Darren K.
    [J]. CIRCULATION, 2022, 146 (08) : 652 - 654
  • [6] Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors?
    Volpe, Massimo
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (44) : 4232 - 4233
  • [7] Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial
    Cosentino, F.
    Cannon, C. P.
    Cherney, D. Z. I.
    Dagogo-Jack, S.
    Pratley, R. E.
    Charbonnel, B.
    Shih, W. J.
    Mancuso, J. P.
    Maldonado, M.
    Frederich, R.
    Cater, N. B.
    Wang, S.
    McGuire, D. K.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2650 - 2650
  • [8] HYPOGLYCEMIA AND CV OUTCOMES IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL
    Pratley, Richard E.
    McGuire, Darren K.
    Fu, Wei
    Cannon, Christopher P.
    Cherney, David Z. I.
    Cosentino, Francesco
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Dagogo-Jack, Samuel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2062 - 2062
  • [9] Should Cardiologists Risk-stratify Patients With Atherosclerotic Cardiovascular Disease by Kidney Function? Results From the VERTIS CV Trial Evaluating Efficacy of Ertugliflozin on Cardiovascular and Kidney Outcomes by Baseline Kidney Function
    Cherney, David
    Charbonnel, Bernard
    Cosentino, Francesco
    Pratley, Richard
    Dagogo-Jack, Samuel
    Shih, Weichung J.
    McGuire, Darren K.
    Frederich, Robert
    Maldonado, Mario
    Liu, Jie
    Pong, Annpey
    Liu, Chih-Chin
    Cannon, Christopher P.
    [J]. CIRCULATION, 2020, 142 (24) : E483 - E483
  • [10] Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy
    Lingvay, Ildiko
    Greenberg, Michelle
    Gallo, Silvina
    Shi, Harry
    Liu, Jie
    Gantz, Ira
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1640 - 1651
12345